7H-Pyrrolo(2,3-d)pyrimidine, 4-chloro-

Specifications

3680-69-1CAS Number

628-079-2EC Number

4-chloro-7H-pyrrolo[2,3-d]pyrimidineIUPAC Name

C6H4ClN3Chemical Formula

153.57 g/molMolecular Weight

4-Chloro-7H-pyrrolo[2,3-d]pyrimidine; 3680-69-1; 4-Chloropyrrolo[2,3-d]pyrimidine; 4-Chloro-1H-pyrrolo[2,3-d]pyrimidine; 4-Chloropyrrolo(2,3-d)pyrimidine; 7H-Pyrrolo(2,3-d)pyrimidine, 4-chloro-; 9VV5MK5RX3; NSC 64952; BRN 0607871; 7H-Pyrrolo[2,3-d]pyrimidine, 4-chloro-; NSC-64952; 4-Chloro-1H-pyrrolo(2,3-d)pyrimidine; DTXSID70190280; 4-Chloro-7H-pyrrolo(2,3-d)pyrimidine; RefChem:106671; DTXCID80112771; 628-079-2; BPTCCCTWWAUJRK-UHFFFAOYSA-N; 6-Chloro-7-deazapurine; MFCD01686865; Tofacitinib Impurity 06; MLS002693495; tofacitinib intermediate; 1H-Pyrrolo[2,3-d]pyrimidine, 4-chloro-; NSC64952; Chloro-7-deazapurine; 4-chloro-7H-pyrrolo-(2,3-d)pyrimidine; 6-chloro-7-deaza purine; UNII-9VV5MK5RX3; 4-CHLORO-3H-PYRROLO[2,3-D]PYRIMIDINE; NCIOpen2_000244; SCHEMBL102201; SCHEMBL102202; orb3142784; 6-Chloro-7-deazapurine, 97%; CHEMBL2133071; SCHEMBL17801003; SCHEMBL27887361; TPL0197; HMS3085B16; 4-chloro-pyrrolo[2,3-d]pyrimidine; ALBB-010107; CS-B0456; CL3424; SBB050204; 4-Chlor-7H-pyrrolo[2,3-d]pyrimidin; 4-chloro-7hpyrrolo[2,3-d]pyrimidine; 4chloro-7H-pyrrolo[2,3-d]pyrimidine; AKOS005070307; AKOS015966378; 4-chloro-7H-pyrrolo[2,3-d]primidine; AC-2838; FC04691; GS-6804; PB12763; 4-Chloro-7H-pyrrolo(2,3,D)pyrimidine; 4-chloro-1H-pyrrolo-[2,3-d]pyrimidine; 4-chloro-7H-pyrrolo[2,3-d]-pyrimidine; 4-chloro-7H-pyrrolo[2,3-d]pyr-imidine; AS-31013; HY-40351; SMR001559448; SY003080; 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine #; DB-031261; DB-358224; C2306; EN300-56508; 3Z-0603; F043654; F5608-0080; Z857668178Synonyms